Clinical Trials Directory

Trials / Completed

CompletedNCT01113112

Biobehavioral-Cytokine Interactions in Ovarian Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
613 (actual)
Sponsor
Susan Lutgendorf · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to understand relationships between behavioral factors, hormones, and chemicals produced by the body that may help tumor growth in ovarian cancer.

Detailed description

Ovarian cancer is the second most common gynecologic cancer. Because of low rates of survival for the majority of ovarian cancer patients, identification of factors contributing to tumor progression is of paramount importance. Epidemiologic studies have suggested an association between biobehavioral factors such as life stress, depression, low social support and cancer progression. Direct links have been demonstrated between biobehavioral factors and cytokines supporting angiogenesis, the formation of new blood vessels that enhance tumor growth and progression. However, little is known regarding tumor associated macrophages (TAM) and interactions between TAM tumor cells in a way that favors tumor growth, but there is preliminary data indicating that ovarian cancer patients with higher levels of depressive symptoms and life stress have greater TAM production of matrix metalloproteinase-9, a key molecule promoting angiogenesis and tumor invasion. We also have preliminary data that ovarian cancer patients with high levels of depressive symptoms accompanied by low social support have greater tumor expression of a number of genes related to inflammation and tumor progression.

Conditions

Timeline

Start date
2003-08-01
Primary completion
2015-11-10
Completion
2026-01-02
First posted
2010-04-29
Last updated
2026-02-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01113112. Inclusion in this directory is not an endorsement.